Risk Paradigm Group’s GSK GSK Stock Holding History

Risk Paradigm Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,040	Closed	-$50.8K	–	138
2018 Q1	$50.8K	Buy	1,040 +80	+8%	+$3.73K	0.06%	146
2017 Q4	$42.6K	Hold	960	–	–	0.05%	167
2017 Q3	$48.7K	Sell	960 -40	-4%	-$2.03K	0.06%	142
2017 Q2	$53.9K	Sell	1,000 -40	-4%	-$2.13K	0.06%	147
2017 Q1	$54.8K	Hold	1,040	–	–	0.06%	138
2016 Q4	$50.1K	Sell	1,040 -714	-41%	-$35.3K	0.06%	161
2016 Q3	$94.6K	Hold	1,754	–	–	0.07%	135
2016 Q2	$95K	Hold	1,754	–	–	0.13%	112
2016 Q1	$88.9K	Hold	1,754	–	–	0.11%	98
2015 Q4	$88.5K	Buy	1,754 +728	+71%	+$37.1K	0.1%	99
2015 Q3	$49.3K	Buy	1,026 +244	+31%	+$12.7K	0.1%	91
2015 Q2	$40.7K	Buy	782 +62	+9%	+$3.49K	0.04%	126
2015 Q1	$41.5K	Buy	+720	New	+$41.3K	0.04%	123

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Risk Paradigm Group's GSK Position: Q2 2018 in Review

Risk Paradigm Group sold out of GSK (GSK) in Q2 2018, closing a stake of 1,040 shares — an estimated $50.8K sold.

Risk Paradigm Group first reported a position in GSK in Q1 2015 and held it in 13 quarters. The position peaked at $95K in Q2 2016. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

Risk Paradigm Group reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
Risk Paradigm Group sold 1,040 GSK shares in Q2 2018, an estimated $50.8K.
Risk Paradigm Group first reported a position in GSK in Q1 2015 and held it in 13 quarters.
Risk Paradigm Group's GSK position peaked at $95K in Q2 2016.
787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.